CollPlant Biotechnologies Ltd

CLGN Nasdaq CIK: 0001631487

Company Information

Industry Orthopedic, Prosthetic & Surgical Appliances & Supplies
SIC Code 3842
Entity Type other
SEC Category Non-accelerated filer
State of Incorporation Israel
Business Address 4 OPPENHEIMER ST., 11TH FLOOR, REHOVOT, L3, 74140
Mailing Address 4 OPPENHEIMER ST., 11TH FLOOR, REHOVOT, L3, 74140
Phone 972-73-232-5600
Fiscal Year End 1231
EIN 000000000

Financial Overview

FY2025 FY

$10.96M
Revenue
-$7.02M
Net Income
$5.25M
Total Liabilities
$32.28M
Stockholders' Equity
$11.91M
Cash & Equivalents
$-0.62
EPS

Recent SEC Filings

Form Type Date Filed Document
F-1 Foreign company IPO registration March 30, 2026 View on SEC
20-F Foreign company annual report March 26, 2026 View on SEC
6-K Foreign company current report March 26, 2026 View on SEC
6-K Foreign company current report March 24, 2026 View on SEC
3 Initial insider ownership report March 19, 2026 View on SEC
3 Initial insider ownership report March 18, 2026 View on SEC
3 Initial insider ownership report March 18, 2026 View on SEC
3 Initial insider ownership report March 18, 2026 View on SEC
3 Initial insider ownership report March 18, 2026 View on SEC
3 Initial insider ownership report March 18, 2026 View on SEC

Annual Reports

20-F March 26, 2026
  • Proprietary rhCollagen technology derived from tobacco plants avoids animal-derived disease risks.
  • Strategic partnership with AbbVie for regenerative breast implants with a deal value exceeding $100 million.
View Analysis

Related Companies

Companies in the same industry (SIC: 3842)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.